• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度心血管疾病流行趋势——关于背景因素及潜在解决方案的观点

The burgeoning cardiovascular disease epidemic in Indians - perspectives on contextual factors and potential solutions.

作者信息

Kalra Ankur, Jose Arun Pulikkottil, Prabhakaran Poornima, Kumar Ashish, Agrawal Anurag, Roy Ambuj, Bhargava Balram, Tandon Nikhil, Prabhakaran Dorairaj

机构信息

Cardiovascular Institute, Kalra Hospitals, New Delhi, India.

Centre for Chronic Conditions and Injuries, Public Health Foundation of India, Gurugram, Haryana, India.

出版信息

Lancet Reg Health Southeast Asia. 2023 Feb 10;12:100156. doi: 10.1016/j.lansea.2023.100156. eCollection 2023 May.

DOI:10.1016/j.lansea.2023.100156
PMID:37384064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10305862/
Abstract

Cardiovascular diseases (CVD) are the leading cause of death and disability in India. The CVD epidemic in Indians is characterized by a higher relative risk burden, an earlier age of onset, higher case fatality and higher premature deaths. For decades, researchers have been trying to understand the reason for this increased burden and propensity of CVD among Indians. It can partly be explained by population-level changes and the remaining by increased inherent biological risk. While increased biological risk can be attributed to phenotypic changes caused by early life influences, six major transitions can be considered largely responsible for the population-level changes in India-epidemiological, demographic, nutritional, environmental, social-cultural and economic. Although conventional risk factors explain substantial population attributable risk, the thresholds at which these risk factors operate are different among Indians compared with other populations. Therefore, alternate explanations for these ecological differences have been sought and multiple hypotheses have been proposed over the years. Prenatal factors that include maternal and paternal influences on the offspring, and postnatal factors, ranging from birth through childhood, adolescence and young adulthood, as well as inter-generational influences have been explored using the life course approach to chronic disease. In addition to this, recent research has illustrated the importance of the role of inherent biological differences in lipid metabolism, glucose metabolism, inflammatory states, genetic predispositions and epigenetic influences for the increased risk. A multifaceted and holistic approach to CVD prevention that takes into consideration population-level as well as biological risk factors would be needed to control the burgeoning CVD epidemic among Indians.

摘要

心血管疾病(CVD)是印度死亡和残疾的主要原因。印度人的心血管疾病流行具有相对风险负担更高、发病年龄更早、病死率更高和过早死亡更多的特点。几十年来,研究人员一直在试图弄清楚印度人心血管疾病负担增加和患病倾向上升的原因。部分原因可以用人口层面的变化来解释,其余原因则是内在生物风险增加。虽然生物风险增加可归因于早期生活影响引起的表型变化,但在印度,有六个主要转变在很大程度上导致了人口层面的变化,即流行病学、人口统计学、营养、环境、社会文化和经济方面的转变。尽管传统风险因素解释了相当大比例的人群归因风险,但与其他人群相比,这些风险因素在印度人身上发挥作用的阈值有所不同。因此,多年来人们一直在寻找对这些生态差异的其他解释,并提出了多种假设。利用慢性病的生命历程方法,人们探索了产前因素(包括母体和父体对后代的影响)以及从出生到童年、青少年和青年期的产后因素,还有代际影响。除此之外,最近的研究表明,脂质代谢、葡萄糖代谢、炎症状态、遗传易感性和表观遗传影响等内在生物差异在增加风险方面所起的作用至关重要。需要采取一种多方面、全面的方法来预防心血管疾病,该方法要同时考虑人口层面和生物风险因素,以控制印度人中迅速增长的心血管疾病流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec1/10305862/91b0852914bb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec1/10305862/417c9b12d133/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec1/10305862/0758b1dd5132/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec1/10305862/91b0852914bb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec1/10305862/417c9b12d133/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec1/10305862/0758b1dd5132/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec1/10305862/91b0852914bb/gr3.jpg

相似文献

1
The burgeoning cardiovascular disease epidemic in Indians - perspectives on contextual factors and potential solutions.印度心血管疾病流行趋势——关于背景因素及潜在解决方案的观点
Lancet Reg Health Southeast Asia. 2023 Feb 10;12:100156. doi: 10.1016/j.lansea.2023.100156. eCollection 2023 May.
2
Cardiovascular Diseases in India: Current Epidemiology and Future Directions.印度心血管疾病:当前流行病学及未来方向。
Circulation. 2016 Apr 19;133(16):1605-20. doi: 10.1161/CIRCULATIONAHA.114.008729.
3
Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study.妊娠合并高血压疾病与儿童、青少年和青年早期心血管疾病:一项全国基于人群的队列研究。
PLoS Med. 2021 Sep 28;18(9):e1003805. doi: 10.1371/journal.pmed.1003805. eCollection 2021 Sep.
4
Cardiovascular disease risk factors in Asian Indian population: A systematic review.亚洲印度人群中的心血管疾病风险因素:一项系统综述。
J Cardiovasc Dis Res. 2013 Dec;4(4):222-8. doi: 10.1016/j.jcdr.2014.01.004. Epub 2014 Feb 18.
5
High mortality from cardiovascular disease and analysis of risk factors in Indian and Melanesian Fijians.印度裔和美拉尼西亚裔斐济人中心血管疾病的高死亡率及危险因素分析
Int J Epidemiol. 1996 Feb;25(1):59-69. doi: 10.1093/ije/25.1.59.
6
Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up.母亲在怀孕期间患糖尿病与后代心血管疾病的早发:一项具有 40 年随访的基于人群的队列研究。
BMJ. 2019 Dec 4;367:l6398. doi: 10.1136/bmj.l6398.
7
IndEcho study: cohort study investigating birth size, childhood growth and young adult cardiovascular risk factors as predictors of midlife myocardial structure and function in South Asians.IndEcho研究:一项队列研究,调查南亚人群中出生时的体型、儿童期生长发育及青年期心血管危险因素作为中年心肌结构和功能预测指标的情况。
BMJ Open. 2018 Apr 10;8(4):e019675. doi: 10.1136/bmjopen-2017-019675.
8
The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.南亚人代谢综合征:流行病学、决定因素与预防。
Metab Syndr Relat Disord. 2009 Dec;7(6):497-514. doi: 10.1089/met.2009.0024.
9
Reducing the burden of coronary artery disease in India: challenges and opportunities.减轻印度冠状动脉疾病负担:挑战与机遇
Indian Heart J. 2008 Mar-Apr;60(2):161-75.
10

引用本文的文献

1
Neuro-cognitive profile of adult statin users at a large tertiary care hospital in Delhi, India.印度德里一家大型三级护理医院成年他汀类药物使用者的神经认知概况。
JRSM Cardiovasc Dis. 2025 Sep 3;14:20480040251371770. doi: 10.1177/20480040251371770. eCollection 2025 Jan-Dec.
2
Early lipid genetics: identification of common and rare genetic variants for lipid traits in Indian adolescents.早期脂质遗传学:印度青少年脂质性状常见和罕见遗传变异的鉴定
J Hum Genet. 2025 Aug 21. doi: 10.1038/s10038-025-01388-0.
3
Cardiovascular Disease (CVD) Risk Assessment Among University Employees in India and Its Implications on Planning Worksite CVD Prevention and Health Promotion Interventions.

本文引用的文献

1
Protocol for a cluster randomised trial evaluating a multifaceted intervention starting preconceptionally-Early Interventions to Support Trajectories for Healthy Life in India (EINSTEIN): a Healthy Life Trajectories Initiative (HeLTI) Study.评估起始于孕前的多方面干预措施的整群随机试验方案——印度支持健康生活轨迹的早期干预(EINSTEIN):健康生活轨迹倡议(HeLTI)研究。
BMJ Open. 2021 Feb 16;11(2):e045862. doi: 10.1136/bmjopen-2020-045862.
2
Ensemble averaging based assessment of spatiotemporal variations in ambient PM concentrations over Delhi, India, during 2010-2016.基于集合平均法对2010 - 2016年印度德里市环境空气中颗粒物浓度时空变化的评估。
Atmos Environ (1994). 2020 Mar 1;224. doi: 10.1016/j.atmosenv.2020.117309. Epub 2020 Jan 27.
3
印度大学员工心血管疾病(CVD)风险评估及其对规划工作场所CVD预防和健康促进干预措施的影响。
Cureus. 2025 Jun 24;17(6):e86642. doi: 10.7759/cureus.86642. eCollection 2025 Jun.
4
Interventions to lower cardiovascular disease risk factors among Asian Indian immigrants: a scoping review protocol.降低亚洲印度移民心血管疾病风险因素的干预措施:一项范围综述方案
BMJ Open. 2025 Jul 20;15(7):e100339. doi: 10.1136/bmjopen-2025-100339.
5
Understanding 30-Day Mortality After First STEMI Through DAGs: Unravelling Epidemiological Cause-Effect Links.通过有向无环图理解首次ST段抬高型心肌梗死后30天死亡率:揭示流行病学因果关系
Cureus. 2025 Jun 16;17(6):e86178. doi: 10.7759/cureus.86178. eCollection 2025 Jun.
6
The epidemiology and burden of atherosclerotic cardiovascular disease in China from 1990 to 2021: findings from the global burden of disease 2021.1990年至2021年中国动脉粥样硬化性心血管疾病的流行病学及负担:全球疾病负担研究2021的结果
Front Public Health. 2025 Jun 26;13:1529506. doi: 10.3389/fpubh.2025.1529506. eCollection 2025.
7
A Comprehensive Review of the Clinical Evidence on the Efficacy, Effectiveness, and Safety of Silodosin for the Treatment of Benign Prostatic Hyperplasia.西洛多辛治疗良性前列腺增生症的疗效、有效性及安全性的临床证据综合综述
Cureus. 2025 Jun 5;17(6):e85445. doi: 10.7759/cureus.85445. eCollection 2025 Jun.
8
Unveiling Cardiovascular Risk Among Older Adults in Eastern India: A Community-Based Cross-Sectional Study.揭示印度东部老年人的心血管风险:一项基于社区的横断面研究。
Cureus. 2025 May 29;17(5):e85063. doi: 10.7759/cureus.85063. eCollection 2025 May.
9
Awareness of Stroke and Preventive Measures Among Hypertensive Patients in a Tertiary Care Hospital: A Cross-Sectional Survey.三级护理医院高血压患者的卒中知晓率及预防措施:一项横断面调查
Cureus. 2025 Apr 29;17(4):e83222. doi: 10.7759/cureus.83222. eCollection 2025 Apr.
10
Cardiac Evaluation in Liver Transplant Candidates.肝移植候选者的心脏评估
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102554. doi: 10.1016/j.jceh.2025.102554. Epub 2025 Mar 27.
Developing "Vital Capacity" in Cardiovascular Risk Assessment.在心血管风险评估中发展“肺活量”。 (注:这里的“肺活量”在心血管风险评估语境下可能是一种类似概念,具体含义需结合上下文确定其准确意义,单从字面看表述不太常规,可能是特定领域的一种说法。)
Circulation. 2019 Oct 15;140(16):1291-1292. doi: 10.1161/CIRCULATIONAHA.119.041745. Epub 2019 Oct 14.
4
Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.脂蛋白(a):印度年轻人群中未被充分认识的恶性冠状动脉疾病遗传危险因素。
Indian Heart J. 2019 May-Jun;71(3):184-198. doi: 10.1016/j.ihj.2019.04.007. Epub 2019 May 2.
5
The burden of child and maternal malnutrition and trends in its indicators in the states of India: the Global Burden of Disease Study 1990-2017.印度各州儿童和孕产妇营养不良负担及其指标趋势:1990-2017 年全球疾病负担研究。
Lancet Child Adolesc Health. 2019 Dec;3(12):855-870. doi: 10.1016/S2352-4642(19)30273-1. Epub 2019 Sep 18.
6
Ethnicity and spirometric indices: hostage to tunnel vision?种族与肺量计指标:是否受限于狭隘视角?
Lancet Respir Med. 2019 Sep;7(9):743-744. doi: 10.1016/S2213-2600(19)30204-8. Epub 2019 Jun 14.
7
Tale of two Indians: Heterogeneity in type 2 diabetes pathophysiology.两位印度人的故事:2 型糖尿病发病机制的异质性。
Diabetes Metab Res Rev. 2019 Nov;35(8):e3192. doi: 10.1002/dmrr.3192. Epub 2019 Jul 29.
8
Microeconomic Costs, Insurance, and Catastrophic Health Spending Among Patients With Acute Myocardial Infarction in India: Substudy of a Randomized Clinical Trial.印度急性心肌梗死患者的微观经济成本、保险和灾难性卫生支出:一项随机临床试验的子研究。
JAMA Netw Open. 2019 May 3;2(5):e193831. doi: 10.1001/jamanetworkopen.2019.3831.
9
High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India.印度城市健康男性献血者中非酒精性脂肪性肝病的高患病率。
JGH Open. 2019 Jan 16;3(2):133-139. doi: 10.1002/jgh3.12117. eCollection 2019 Apr.
10
Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort.队列资料简介:特里凡得琅非酒精性脂肪性肝病(NAFLD)队列。
BMJ Open. 2019 May 5;9(5):e027244. doi: 10.1136/bmjopen-2018-027244.